Urology News

Prostate Cancer

Metastatic Prostate Cancer: Investigators Ponder New Path to Improve Survival

Publish Date September 30, 2022

Greater effort should be directed at detecting and aggressively treating prostate cancer metastasis earlier, an approach made possible with the advent of highly sensitive and specific molecular imaging techniques and potent anticancer agents.

Prostate Cancer

Coffee Intake Linked to Longer Prostate Cancer-Specific Survival

Publish Date September 30, 2022

Longer prostate cancer-specific survival seen for specific subgroups, including those with the CYP1A2 AA genotype

Prostate Cancer

PSMA PET/CT Lymph Node Staging Can Predict Prostate Cancer Surgery Outcomes

Publish Date September 29, 2022

Pelvic lymph node metastases visualized on PSMA PET/CT prior to prostate cancer surgery independently predicts an increased risk for biochemical disease progression, a study found.

Bladder Cancer

Local Docetaxel Therapy May Benefit Patients With High-Risk NMIBC

Publish Date September 28, 2022

Of 19 patients with high-risk NMIBC treated with local docetaxel, 14 had prior BCG exposure.

Kidney Cancer

T1a RCC Death Risk Higher After Ablation vs Partial Nephrectomy

Publish Date September 27, 2022

Study included a large, contemporary cohort of patients with T1a renal cell carcinoma undergoing partial nephrectomy or local tumor destruction.

Prostate Cancer

Severity of Sleep Apnea and Related Hypoxia Tied to Cancer

Publish Date September 27, 2022

Sleep apnea and related hypoxia more severe in obstructive sleep apnea patients with cancer compared with those without cancer

Urology

Acupuncture and Moxibustion for Insomnia Relief in Cancer Patients

Publish Date September 26, 2022

Acupuncture and moxibustion, which are sometimes used together, have shown promise in reducing insomnia in patients with cancer.

Kidney Cancer

Follow-Up Confirms DFS Benefit With Pembrolizumab in Clear Cell RCC

Publish Date September 23, 2022

Adjuvant pembrolizumab could be a new standard of care for patients with clear cell renal cell carcinoma at increased risk of recurrence after nephrectomy, according to researchers.

Kidney Cancer

Real-World Data Support Nivolumab + Ipilimumab for First-Line mRCC Therapy

Publish Date September 22, 2022

Study revealed an objective response rate consistent with that observed in the CheckMate 214 clinical trial and a low rate of treatment-related adverse events.

Benign Prostatic Hyperplasia (BPH)

Erectile Function Mostly Not Impacted by Surgery for BPH

Publish Date September 22, 2022

But rate of retrograde ejaculation higher following many surgical procedures for benign prostatic hyperplasia